Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition • 09-14 May 2026
| 08:20 |
|
405-02-001.
Four-year changes in white matter tract profiles characterize microstructural evolution in multiple sclerosis
Impact: Longitudinal relationships in tract profiles of myelin water fraction and fractional anisotropy were evaluated in healthy controls and individuals with multiple sclerosis. Relationships captured evolving microstructural changes in multiple sclerosis, reflecting disease-related changes otherwise difficult to detect.
|
|
| 08:31 |
|
405-02-002.
Dynamic changes in sodium (23Na) neurite-fractions uncover the early phase of potentially reversible cellular energy distress
Impact: By disentangling
reversible from irreversible energetic dysfunction with 7T ²³Na-MRI and NODDI,
we identified patient-specific energetic penumbra not yet coupled to
neurodegeneration. This metric could stratify trials, refine prognosis and time
neuroprotective therapies to a biologically plausible rescue window.
|
|
| 08:42 |
|
405-02-003.
MRI-Derived Subtypes Identified by SuStaIn Capture Distinct Clinical, Cognitive and Disability Profiles in Multiple Sclerosis
Impact: This study shows that SuStaIn-derived MRI
subtypes reveal biologically distinct multiple sclerosis forms, differing in
clinical phenotype, age at onset, disability, and cognition, offering a
powerful tool to enhance patient stratification and enable precision medicine
in multiple sclerosis.
|
|
| 08:53 |
|
405-02-004.
Paramagnetic Changes in Multiple Sclerosis: Imaging-Pathology Correlations
Impact: Paramagetic Rim Lesions (PRL) have been proposed as an MRI-visible indicator of chronic immune activity in Multiple Sclerosis (MS). However, imaging-histology comparison suggests that the degree PRL reflect relevant pathology is unclear. Further research is required to adequately interpret PRL.
|
|
| 09:04 |
|
405-02-005.
Performance of Myelin Water Imaging in vivo: Imaging-Histopathologic Correlation in Toxin-Induced Demyelination
Impact: This work
highlights the potential effects of both de/remyelination and inflammation on
MWF signal and provides a framework for rigorous preclinical
MRI–histopathologic validation. These insights help advance MWF toward use as a
reliable quantitative endpoint in remyelination trials.
|
|
| 09:15 |
|
405-02-006.
The Pathological Contributors to Mean Diffusivity: A Postmortem 9.4T MRI Study on Multiple Sclerosis Brain Lesions
Impact: This work improves our understanding of clinically relevant microstructural contributors to the MD signal and shows potential to enhance the clinical interpretation of DWI derived contrasts.
|
|
| 09:26 |
|
405-02-007.
Sex-Related Differences in White Matter Hyperintensity Segmentation: Insights from Six Automated Methods
Impact: Automated white matter hyperintensity (WMH) segmentation across six methods reveals sex-specific performance differences. Assessing and investigating such disparities is essential to ensure fair algorithmic performance, improve diagnostic accuracy, and support sex-specific clinical and research decisions.
|
|
| 09:37 |
|
405-02-008.
Subvoxel QSM Quantification of Juxtacortical Paramagnetic Rims and Their Clinical Correlates in Multiple Sclerosis
Impact: Subvoxel QSM reveals distinct iron and myelin patterns in cortical lesions (CLs), identifying juxtacortical paramagnetic rims (JPRs) as a potential biomarker of irreversible cortical damage, cognitive impairment, and relapse risk in multiple sclerosis (MS).
|
|
| 09:48 |
|
405-02-009.
χ-Separation Reveals Iron-Related Inflammation in Multiple Sclerosis Lesions
Impact: This study shows that χ-separation provides a
quantitative marker of iron-driven chronic inflammation within paramagnetic rim
lesions in multiple sclerosis. These measures improve clinical characterization
and phenotype differentiation, opening new avenues for monitoring lesion
activity directly in vivo.
|
|
| 09:59 |
|
405-02-010.
In multiple sclerosis skull TSPO overexpression by 11C-PBR28 MR-PET associates with clinical disability and neurodegeneration
Impact: Skull bone TSPO emerges as a novel imaging biomarker of multiple sclerosis progression and a potential target for future therapeutic intervention
|
© 2026 International Society for Magnetic Resonance in Medicine